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AbsTrACT
background The global burden of road injuries is known 
to follow complex geographical, temporal and demographic 
patterns. While health loss from road injuries is a major 
topic of global importance, there has been no recent 
comprehensive assessment that includes estimates for every 
age group, sex and country over recent years.
Methods We used results from the Global Burden 
of Disease (GBD) 2017 study to report incidence, 
prevalence, years lived with disability, deaths, years of 
life lost and disability- adjusted life years for all locations 
in the GBD 2017 hierarchy from 1990 to 2017 for road 
injuries. Second, we measured mortality- to- incidence 
ratios by location. Third, we assessed the distribution 
of the natures of injury (eg, traumatic brain injury) that 
result from each road injury.
results Globally, 1 243 068 (95% uncertainty interval 
1 191 889 to 1 276 940) people died from road injuries in 
2017 out of 54 192 330 (47 381 583 to 61 645 891) new 
cases of road injuries. Age- standardised incidence rates 
of road injuries increased between 1990 and 2017, while 
mortality rates decreased. Regionally, age- standardised 
mortality rates decreased in all but two regions, South 
Asia and Southern Latin America, where rates did not 
change significantly. Nine of 21 GBD regions experienced 
significant increases in age- standardised incidence rates, 
while 10 experienced significant decreases and two 
experienced no significant change.
Conclusions While road injury mortality has improved 
in recent decades, there are worsening rates of incidence 
and significant geographical heterogeneity. These 
findings indicate that more research is needed to better 
understand how road injuries can be prevented.
InTroduCTIon
In the original 1971 formulation of the epidemi-
ological transition, Abdel Omran suggested that a 
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country could be expected to pass through three phases of health 
loss patterns as its economy improved.1 A country would experi-
ence, first, an ‘age of pestilence and famine’ and, second, an ‘age 
of receding pandemics’. The third phase would include increased 
burden from ‘degenerative and man- made diseases’, a phase that 
in their 2002 review Salomon and Murray summarised as health 
loss from ‘cancers, cardiovascular diseases, and accidents’.2 This 
work on the epidemiological transition provides a starting point 
for reviewing the current global burden of road injuries and for 
investigating the relationship between road injuries and economic 
development. The burden of road injuries has become an area of 
particular focus across global forums in recent years. In March 
2010, the United Nations (UN) General Assembly proclaimed 
2011–2020 as the Decade of Action for Road Safety.3 In 2015, the 
UN General Assembly established Sustainable Development Goal 
3.6 as the target of reducing road traffic deaths and injuries by 50% 
by 2020.4 More recently, the WHO published the Global Status 
Report on Road Safety 2018 and established focus on road safety 
goals with performance targets in the WHO’s General Programme 
of Work 2019–2023.5 Efforts such as Vision Zero have developed 
cross- setting efforts ranging from countries in Europe to states in 
India to cities in the USA to develop a road safety paradigm focused 
on reducing road injury burden to zero.6 The European Transport 
Safety Council has developed evidence- based guidance on trans-
port safety improvements in Europe, while the Insurance Institute 
for Highway Safety in the USA has conducted research on the 
science of highway safety and on safety profiles of different vehi-
cles. Globally, the International Transport Forum has developed 
important resources to guide transport safety improvements on a 
global basis across multiple modes of transport. The complexity of 
road safety science has advanced such that entire textbooks now 
focus on the elements of road safety ranging from behavioural 
science to economic relationships.7 Across these efforts, it is 
evident that it is now more critical than ever for legislative poli-
cymakers, ministries of health, transportation sectors, academic 
research groups and other agencies to work collaboratively with 
a Safe System paradigm on improving road safety.8 Measurement 
of road injury burden is a critical component of advancing these 
initiatives.
Many other studies have measured road injury burden using 
different methods and data sources including updates to the Global 
Burden of Disease (GBD) Study, road safety reports by the WHO 
and reports or studies published by other groups.9–12 While past 
research has been instrumental in advancing road safety initia-
tives, it is also important to produce regular updates of road injury 
burden estimates. Updates that include recent years are critical 
to ensuring that the effects of economic development, new poli-
cies and new safety technologies can be observed and discussed 
with minimal latency. Timeliness of updating road injury burden 
estimates helps ensure that policymakers and health resources 
researchers appropriately focus their efforts, and historically 
evidence- informed policies regarding road injuries have been 
impactful. For example, research on road injury burden in Iran 
in the early 2000s led to new policies being enacted to address 
the growing burden, while elsewhere in countries such as the USA 
and Australia, legislation focused on intoxicated driving, seat-
belt requirements, speed controls and vehicle safety have likely 
contributed to decreasing mortality rates from road injuries in 
select areas.13–16 In cases where road safety legislation has been 
passed, successful implementation of such policies is also crit-
ical, and it is also not clear the extent to which successful policy 
in one location can be equally successful elsewhere. Road injuries 
are a unique cause of morbidity and mortality on the global land-
scape because unlike diseases and injuries for which there may be 
considerable lag between burden measurement, policy implemen-
tation and burden improvement, road injury burden can change 
rapidly if measures such as seatbelt laws, intoxicated driving laws 
and infrastructure improvements are implemented.17–20 Hence, it 
is important to continue regular updates of health assessments that 
measure morbidity and mortality from road injuries, as preventing 
and treating road injuries is of critical importance for sustain-
able improvements in population health outcomes and warrants 
detailed analysis to understand sociodemographic patterns as well 
as geographical trends over time.
The Global Burden of Diseases, Injuries, and Risk Factors Study 
(GBD) is a comprehensive assessment of health loss to measure 
morbidity and mortality from a wide array of diseases, injuries and 
risk factors.11 12 21–24 The study involves a global network of over 
3500 collaborators who provide broad expertise on diseases, inju-
ries, risk factors and locations. The study is published on an annual 
basis, so estimates are frequently updated with new input data and 
methodological improvements. GBD 2017 was published in 2018 
and included road injuries as one of 30 mutually exclusive, collec-
tively exhaustive injury- related causes of death and disability. In 
the GBD, road injuries encompass injuries involving motor vehi-
cles, pedestrians, motorcyclists and cyclists. GBD 2017 included 
estimates of road injury morbidity and mortality in terms of inci-
dence, prevalence, years lived with disability (YLDs), cause- specific 
mortality, years of life lost (YLLs) and disability- adjusted life years 
(DALYs) for 195 countries and territories, all age groups and both 
sexes, for years between 1990 and 2017.
The objective of this paper is to use the GBD 2017 results 
and framework to provide an updated assessment of the global 
burden of road injuries and to identify trends and patterns that 
may be useful by policymakers, organisations and the private 
sector for preventing future road injury burden.
MeThods
Gbd 2017
GBD 2017 methods and results are described in extensive detail in 
GBD literature, including descriptions of the analytical estimation 
framework used to measure deaths, YLLs, incidence, prevalence, 
YLDs and DALYs for every cause in GBD including injuries.11 12 21–24 
A review of key GBD methods is summarised in online supplemen-
tary appendix 1. The methodological components specific to inju-
ries and road injuries estimation within the GBD framework are as 
follows. All key analytical steps are conducted across 1000 draws, 
and the ordered 25th and 975th values of the final estimates are used 
to determine the 95% uncertainty interval (UI).
Gbd injury classification
Our case definition for a road injury is ‘interaction, as a pedestrian 
on the road, with an automobile, motorcycle, pedal cycle, or other 
vehicles resulting in bodily damage or death’. The GBD cause hier-
archy includes road injuries as an external cause of injury, similar to 
falls or poisoning. These external cause- of- injury codes or ‘E codes’ 
are designated as mutually exclusive and collectively exhaustive in 
the cause hierarchy, meaning that they include every possible cause 
of death or disability either as specific injuries or as residual (‘other’) 
injuries. These external cause- of- injury codes cause nature- of- injury 
codes, which specify the bodily injury that is caused by an external 
cause of injury. In terms of the nature- of- injury codes (eg, the trau-
matic brain injury (TBI) that might be due to a road injury), injuries 
were categorised into 47 mutually exclusive and collectively exhaus-
tive nature- of- injury categories using chapters S and T in the Inter-
national Classification of Diseases (ICD), 10th revision, and codes 
800–999 in ICD-9. Since it is possible that an external cause of injury 
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including a road injury may not actually lead to bodily harm, we only 
include injuries in our morbidity analysis that warranted some form 
of healthcare, which is typically indicated in survey data for road 
injuries and can be inferred from our use of hospital records. For 
example, a low- speed collision (‘fender bender’) that did not lead to 
any bodily injury to drivers, passengers or bystanders would not be 
considered an injury in GBD.
Mortality and YLLs from road injuries
GBD methods for cause of death estimation is provided in GBD 
literature.11 12 21–25 A brief overview of this process is as follows. 
First, all available data sources were accessed and mapped 
into the GBD cause list and cause hierarchy. Road injuries 
data sources included vital registration, verbal autopsy studies, 
mortality surveillance, censuses, surveys, hospital records 
and mortuary data. For road injuries, we used ICD-9 codes 
E800.3, E801.3, E802.3, E803.3, E804.3, E805.3, E806.3, 
E807.3, E810.0- E810.6, E811.0- E811.7, E812.0- E812.7, 
E813.0- E813.7, E814.0- E814.7, E815.0- E815.7, 
E816.0- E816.7, E817.0- E817.7, E818.0- E818.7, 
E819.0- E819.7, E820.0- E820.6, E821.0- E821.6, 
E822.0- E822.7, E823.0- E823.7, E824.0- E824.7, 
E825.0- E825.7, E826.0- E826.1, E826.3- E826.4, E827.0, 
E827.3- E827.4, E828.0, E828.4 and E829.0- E829.4, and ICD-10 
codes V01- V04.99, V06- V80.929, V82- V82.9 and V87.2- V87.3. 
Second, we redistributed ill- defined causes of death to specific 
underlying causes, including road injuries, via a process known as 
garbage code redistribution.12 26 Third, ensemble models for road 
injuries and each subtype were conducted using the GBD Cause 
of Death Ensemble modelling (CODEm) software. CODEm 
employs five principles to build a cause of death model based on 
testing a variety of possible models that have been run through 
several modelling classes using an array of covariates.27 Next, 
an ensemble of best- performing models is constructed based on 
out- of- sample validity testing. The covariates used in the models 
included lag- distributed income per capita (a smoothed series of 
GDP per capita), education per capita in years, alcohol use in 
litres per capita, an indicator for opium cultivation, population 
density over 1000 per square kilometre, a summary exposure 
value for violent injuries, Socio- demographic Index (SDI) and 
Healthcare Access and Quality Index. Deaths for each cause are 
then rescaled such that the sum of deaths across causes equals 
the total deaths, which enforces internal consistency across GBD 
estimates. As a final step, YLLs due to road injuries and each 
subtype are calculated by multiplying deaths by the residual 
life expectancy at the age of death from GBD 2017 standard 
model life table. YLLs measure the number of years of life are 
lost when a death occurs at an age less than the life expectancy; 
for example, if the residual life expectancy at age 25 years is 60, 
then 60 years of life were lost when a person dies at age 25 years.
Incidence, prevalence and YLds due to road injuries
Estimation of non- fatal injury outcomes (incidence, prevalence 
and YLDs) in GBD is described in detail in related publications.11 
A summary is as follows. We used DisMod- MR 2.1 (a descriptive 
epidemiological meta- regression tool) to model incidence data for 
road injuries from emergency department and hospital records and 
survey data to estimate incidence by location, year, age and sex. These 
models were conducted for each subtype of road injuries. We used 
cause- specific mortality rates and incidence data to compute excess 
mortality rates following an injury since DisMod- MR 2.1 functions 
in a compartmental framework such that all incident cases of injury 
must be explained by dying, remaining prevalent or going into 
remission. Our assumption that case fatality rates are higher in lower 
income setting is implemented by adding lag- distributed income per 
capita as a covariate on excess mortality, which causes a negative 
relationship between income and mortality. This assumption is based 
on the observation that more sophisticated forms of treatment such 
as intensive care units (ICU), ventilator support and surgery may be 
required for higher acuity injuries resulting from road injuries.
After incidence cause models were conducted for each type of 
road injury, we split the cause incidence into inpatient and outpa-
tient incidence based on a coefficient derived in DisMod- MR 
2.1 in locations that had both types of data. Both of these series 
then went through the following steps. We developed a severity 
hierarchy of nature- of- injury types by using pooled datasets of 
follow- up studies from China, the Netherlands and the USA where 
health status 1 year after injury could be mapped to existing GBD 
disability weights.28–34 This severity hierarchy was used to identify 
the injury that would cause the most disability in the event that 
a road injury lead to multiple types of injuries (eg, a spinal cord 
transection and a wrist fracture).
Next, recognising that injury disability is determined by nature of 
injury rather than cause of injury, we estimated the proportion of 
road injuries that would lead to each nature- of- injury type being the 
most severe. We computed these proportions using Dirichlet regres-
sion methods in dual- coded hospital and emergency department data 
where both cause and nature could be identified. This process and the 
data sources used are described in more detail in other GBD studies.35 
Each cause–nature matrix was specific to hospital admission versus 
injury warranting other healthcare, high/low income countries and 
territories, male/female and age category. Deriving these matrices 
separately in this manner allows variation by these variables. We 
then applied these proportions to our cause- of- injury incidence from 
DisMod- MR 2.1 in order to estimate cause–nature incidence. We 
converted these estimates to prevalence using the average duration 
for each nature of nature of injury and for inpatient and outpatient 
injuries from the Dutch Injury Surveillance System with supplemen-
tation from expert- driven estimates of short- term duration for nature 
of injury categories that had insufficient numbers in the Dutch dataset 
and for untreated injuries.31 We measured the probability of long- term 
(permanent) disability to account for the permanence of conditions 
such as spinal cord injury as opposed to the shorter term recovery 
for conditions such as a fibular fracture. The probability of long- term 
disability was based on analysis of long- term follow- up studies.28–34 
Long- term prevalence was then calculated based on the ordinary 
differential equation solver used in DisMod- MR 2.1 to incorporate 
the parameters of incidence and long- term mortality risk for nature- 
of- injury conditions with increased mortality risk (eg, traumatic brain 
injury) such that prevalence is correctly estimated after accounting for 
excess mortality risk. Finally, we calculated YLDs by multiplying the 
prevalence of a health state, as defined in this process as the nature 
of injury, and a disability weight, which has been mapped to these 
injuries in previous GBD research.36 Finally, across all causes in GBD, 
a comorbidity correction is applied to account for comorbidity distri-
butions in the population.11
socio-demographic Index
SDI is an indicator based on the human development index that 
includes income per capita, average educational attainment and 
total fertility rate under 25. Low SDI values correspond to low 
income per capita, low educational attainment and high fertility 
under 25 years, while high values correspond to higher income 
per capita, greater educational attainment and lower fertility under 
25 years. We tabulate some results in this study by SDI quintile in 
order to identify socioeconomic patterns in road injury burden.
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Guidelines for Accurate and Transparent health estimates 
reporting (GATher) compliance
This study complies with the GATHER recommendations (see 
online supplementary appendix 2). Analyses were completed 
using Python version 2.7, Stata V.13.1 or R version 3.3. Statis-
tical code used for GBD estimation is publicly available online 
at  healthdata. org.
resuLTs
Summary results are as follows. Additional results by age, sex, 
year, location and injury cause and nature are available online 
at  healthdata. org. Online resources also allow for measuring 
changes between different years, for example, between 2007 and 
2017 as opposed to 1990 and 2017 as well as reviewing sources 
of data used in GBD 2017.
Incidence
Online supplementary appendix table 1 shows all ages incidence 
counts and age- standardised incidence rates for 2017 as well as the 
percentage change in age- standardised rates from 1990 to 2017 for 
overall road injuries. Countries in the middle SDI quintile experi-
enced the highest increase of incidence rates from 1990 to 2017, 
with a 53.3% (95% UI 47.1 to 59.4) increase. High SDI was the 
only quintile that had decreased incidence rates during that time 
period, with a decrease of 16.5% (11.9 to 21.0). Figure 1 shows 
the new cases and age- standardised incidence rates of road injuries 
for 2017 and the per cent change between 1990 and 2017 for 
age- standardised incidence rates by country and territory. Glob-
ally, the age- standardised incidence rate was 692 (605 to 786) per 
100 000 in 2017, representing an increase of 11.3% (6.4 to 15.8) 
from 1990 to 2017 and corresponding to 54 192 330 (47 381 
583 to 61 645 891) new cases in 2017. Age- standardised incidence 
rates decreased from 1990 to 2017 in 109 out of 195 countries 
and territories, with the largest declines in South Korea, Iraq and 
Portugal, which decreased by 40.6% (33.3 to 46.6), 40.4% (34.5 
to 45.2) and 38.8% (31.9 to 45.5), respectively.
The regions with the highest age- standardised incidence rates 
in 2017 were Central Europe (1467 (1297 to 1687)), Austral-
asia (1304 (1157 to 1480)) and Eastern Europe (1193 (1022 to 
1405)). Among the 21 GBD regions, 10 experienced significant 
decreases in age- standardised incidence rates, 9 regions expe-
rienced significant increases in age- standardised incidence rates 
(with the greatest increases found in East Asia and Oceania) and 
the remaining two regions experienced no significant change in 
age- standardised incidence rates (Central Europe and Central 
Asia). Age- standardised incidence rates decreased the most from 
1990 to 2017 in High- income Asia Pacific, decreasing by 28.3% 
(23.5 to 33.2) and had the greatest increase in East Asia, where 
it increased by 111.2% (101.4 to 120.8). In terms of an age 
pattern, figure 2 shows global age- specific incidence rates for 
each age group by sex in 2017. This figure emphasises how road 
injury incidence is heavily concentrated in young to middle age 
groups and that males experience higher incidence rates than 
females, particularly in young adulthood.
Cause-specific mortality
Online supplementary appendix table 2 shows all ages deaths 
and age- standardised mortality rates for 2017 as well as the 
percentage change in age- standardised rates from 1990 to 2017. 
Globally, the age- standardised mortality rate was 15.8 (15.2 to 
16.3) per 100 000 in 2017, which corresponded to 1 243 068 
(1 191 889 to 1 276 940) deaths in 2017 and represented a 
29.0% (25.0 to 33.6) decrease in age- standardised mortality rate 
from 1990 to 2017. Geographically, figure 3 shows the deaths 
and age- standardised mortality rate from road injuries in 2017 
and the per cent change between 1990 and 2017. This figure 
reveals the general pattern that mortality rates from road injuries 
is highest in select countries in North Africa, the Middle East and 
Southern sub- Saharan Africa in 2017. The countries with the 
highest age- standardised mortality rates were Central African 
Republic (85.5 (50.7 to 111.2) deaths per 100 000), Somalia 
(51.1 (27.8 to 72.0)) and United Arab Emirates (49.9 (39.5 to 
61.1)). China had the highest number of total deaths, with 261 
802 (247 924 to 273 651) deaths estimated in 2017.
YLds, YLLs and dALYs
Online supplementary appendix table 3 shows the counts, age- 
standardised rates and per cent change from 1990 to 2017 of 
YLDs, YLLs and DALYs for road injuries. Globally, in 2017, road 
injuries resulted in 57 638 366 (55 500 786 to 59 369 191) YLLs, 
10 159 667 (7 272 042 to 13 618 818) YLDs and 67 798 033 
(64 337 599 to 71 454 968) DALYs, reflecting age- standardised 
rates of 745 (718 to 767) per 100 000, 126 (90 to 169) and 871 
(828 to 917), respectively. Age- standardised YLLs and DALYs 
decreased by 34.4% (30.4 to 38.5) and 30.8% (26.9 to 35.0), 
respectively, between 1990 and 2017, while age- standardised 
YLDs increased 2.2% (0.3 to 4.0). The region with the highest 
age- standardised DALY rate was Central sub- Saharan Africa with 
1720 (1448 to 1999) DALYs per 100 000, which represented 
1564 (1302 to 1834) YLLs and 156 (114 to 204) YLDs.
Mortality-to-incidence ratios (MIrs)
Figure 4 shows the ratios of age- standardised mortality rates to 
age- standardised incidence rates by region in 1990 and 2017, 
which approximates the risk of death given a road injury. This 
figure shows how the MIRs vary by both time and location. The 
Caribbean had the highest MIR in 2017, while Australasia had 
the lowest, following the pattern of percentage DALYs caused 
by YLDs described above. While MIR varied substantially across 
regions, it also declined in every region from 1990 to 2017.
nature of injuries caused by road injuries
The average global disability weight used in computing YLDs 
after comorbidity adjustment was 5.8%. Figure 5 shows the 
distribution of natures of injury in terms of age- standardised 
prevalence by region. This figure shows that the category of 
injury that includes fractures of patella, tibia or fibula or ankle is 
the leading cause of disability for victims of road injuries. TBI is 
also an important contributor to health loss from road injuries in 
all regions of the world.
dIsCussIon
The Global Status Report on Road Safety in 2018 published by 
the WHO cites important progress in road safety initiatives that 
have made at the country level, such as new legislation oriented to 
road safety, updated vehicle standards and technology and access 
to trauma care.5 For example, 123 out of 175 countries included in 
the report were noted to have best- practice road safety laws imple-
mented for at least one of the key risk factors for road injuries, 
and the report notes progress such as additional countries passing 
legislation and policy related to drink driving, motorcycle helmet 
use and child restraint systems. In this study, we found that despite 
global increases in road injuries incidence between 1990 and 2017, 
cause- specific mortality has decreased over the same time period, 
which likely reflects many of these underlying country- level 
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Figure 1 Incident cases, age- standardised incidence rates, and per cent change between 1990 and 2017 by country for road injuries.
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Figure 2 Age- specific and sex- specific incidence of road injuries globally in 2017.
improvements as described by the WHO. From this summary 
finding, several important themes emerge.
First, the observation of incidence increasing and mortality 
decreasing on the global level implies that while road injuries are 
becoming more frequent, individuals experiencing road injuries 
are less likely to die. It is likely that at least part of the increases 
in incidence can be explained by broadly increasing access to and 
utilisation of motorised transport in all locations of the world 
over the time period of this study, including shifts in types of 
motorised transit (eg, from bicycles to motorbikes) being used. 
This observation may also imply general improvements in case 
fatality rates. Improvements in case fatality rates may be affected 
by two general processes. First, it is possible that improvements 
in infrastructure, driving laws such as seatbelt laws and vehicle 
safety improvements have led to the types of disability sustained 
in road injuries decreasing in severity over time. For example, a 
driver who was in a road incident in 1990 may have been less 
likely to be wearing a seatbelt than a driver in 2017, which could 
have increased the probability of more severe injuries and death 
in 1990 relative to 2017, all else being equal. Similarly, infra-
structure improvements such as improved roads, guard rails and 
streetlights, particularly in developing economies, may have led 
to less morbidity and mortality in each road injury case, even 
if the total number of cases is increasing due to factors such as 
increased rates of driving.37 38 The second possible factor that 
could lead to improvements in case fatality is improvements 
in access to medical care following a road injury. For example, 
adding ambulance services, building trauma centres and ensuring 
access to emergency medical care in all populations is likely to 
be beneficial in terms of improving survival for road injury 
cases, which has been shown in locations that advance trauma 
systems.39 Advances in trauma care over the past three decades 
have led to improved imaging and diagnostic technologies 
being more readily available to global populations, and research 
in trauma resuscitation has led to better understanding of the 
pathology that can occur in a road injury, though postincident 
care in road injuries remains an ongoing area of research.40 41 
It is likely that the implied improvements in case fatality have 
also been affected by improved quality and access to medical 
care on a global scale. Among SDI quintiles, one exception to 
this trend occurred in the highest SDI quintile, which experi-
enced decreases both in incidence and mortality, suggesting that 
concomitant improvements may be possible as socioeconomic 
development continues globally.
Second, while we found global improvements in mortality 
despite increases in incidence, we also observed considerable 
heterogeneity by country and region. Despite global improve-
ments in mortality, multiple countries experienced increases 
in age- standardised cause- specific mortality from road injuries 
during this study period. For example, Paraguay, Chad, Lesotho, 
Pakistan, Mongolia and North Korea experienced increases in 
road injuries mortality, emphasising that despite global improve-
ments, it is important for health policy research to be conducted 
in areas where fatal burden from road injuries is still increasing. 
For example, patients with moderate- to- severe injury that 
received treatment at a level 1 trauma centre in the USA were 
shown to be at a 25% decreased risk of death when compared 
with those who accessed a non- trauma centre, raising the ques-
tion of whether medical infrastructure development could 
produce similar improvements in lower income settings .40 It is 
possible that portions of road injury burden may be mitigated 
by legislation (eg, seatbelt laws), infrastructure and engineering 
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Figure 3 Deaths, age- standardised mortality rates and per cent change between 1990 and 2017 by country for road injuries.
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Figure 4 Changes in mortality- to- incidence ratios by GBD region from 1990 to 2017. GBD, Global Burden of Disease.
(eg, road construction) and behavioural modifications (eg, intox-
icated driving). Yet it is also likely that there are still unidentified 
factors that lead to road injury incidence and mortality, particu-
larly as these trends are likely governed by a wide array of factors 
ranging from trauma pathophysiology to vehicle engineering to 
social behaviours. Future road injury research may benefit from 
more comprehensive syntheses of how various causes and modi-
fiers affect these outcomes, similar to how our understanding of 
cancer, infectious disease and cardiovascular disease has bene-
fited from laboratory- based, translational- based and population- 
based research studies.
Third, we found that changes in incidence and mortality 
varied by development. Specifically, countries and territories 
in the middle SDI quintile experienced the greatest increases in 
age- standardised incidence between 1990 and 2017, while low 
SDI quintile locations increased less, and high SDI quintile loca-
tions actually decreased in terms of incidence. These findings 
are reminiscent of the transition phases described in literature 
on the epidemiological transition, where a country’s burden of 
disease and injury is modulated by where the country is on the 
development spectrum. For example, Papua New Guinea and 
Myanmar, low and low- middle SDI countries, respectively, have 
experienced significant economic growth in the past decade.42 
Both countries have also experienced increased incidence of 
road injuries over the past 10 years, while the burden of commu-
nicable diseases decreased. These country experiences support 
the idea that while countries transition to more stable econo-
mies, road injuries predictively become more burdensome. Inter-
estingly, there is evidence that reductions in road traffic injuries 
have positive effects on GDP per capita, so there is incentive 
for developing countries to prioritise road safety initiatives and 
injury prevention.43
Fourth, for the first time in GBD research, we were able to 
estimate the burden of road injuries in terms of the types of 
disability that road injuries caused. Specifically, we found that 
the most common nature of injury sustained in a road injury 
in all regions was fracture of patella, tibia/fibula or ankle and 
that in most regions, moderate/severe TBIs were the next leading 
cause of disability in road injuries. These are important findings 
for two reasons. Lower extremity fractures can require surgical 
management in order to avoid longer term disability, which 
emphasises the importance of modern medical services including 
surgical services being available in all areas of the world. In addi-
tion, these findings show how disability from road injuries can 
lead to lifelong health loss in the form of conditions like TBI 
that can have irreversible health consequences, emphasising the 
importance of preventative strategies in reducing future burden 
from road injuries.
There were several limitations to this study. First, similar to 
other analyses in GBD research, the uncertainty of road injury 
morbidity and mortality rates is affected by data availability. In 
countries and territories with absent or sparse data, the model-
ling framework relies more on covariates and other locations 
that do have data, which leads to greater uncertainty around the 
point estimates. Greater UIs mean that readers and policymakers 
should use more caution when acting on these results. To address 
this limitation, health systems in the future should prioritise good 
data collection strategies in order to help improve the accuracy 
of future research in road injury burden. Current data limita-
tions, modelling differences and garbage code redistribution, 
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Figure 5 Distribution of most severe nature of injury sustained in road injuries by region in 2017. TBI, traumatic brain injury.
What is already known on the subject
 ► Road injuries are known to be a major cause of health loss 
globally, both in terms of morbidity and mortality.
 ► While progress on mitigating health loss from road injuries 
has been made in some locations, there is still considerable 
morbidity and mortality in all areas of the world, including in 
low- income and middle- income regions.
What this study adds
 ► Road injury incidence has increased globally from 1990 to 
2017, while mortality has decreased.
 ► Trends in mortality- to- incidence ratios for road injuries have 
varied depending on region of the world between 1990 and 
2017.
 ► The specific type of bodily injury occurring in road injuries 
is now estimated, with the most common nature of injury 
sustained in road injuries being a fracture of the patella, tibia 
or fibula, or ankle.
particularly for data- sparse or data- absent locations likely 
account for much of the difference between global mortality 
estimates from the WHO, which estimated 1.35 million deaths 
in 2016, and GBD 2017, which estimated 1.25 million deaths 
in 2016. Second, as described in other GBD literature on injury 
estimation, the current process for assigning disability to a road 
injury case requires predicting the most disabling injury that 
results from a road injury, without taking into consideration the 
possibility that multiple natures of injury can result from a road 
injury. In future GBD research, developing methods to capture 
all forms of disability that result from road injuries could help 
measure the total health loss burden from these conditions. 
Finally, a general limitation of non- fatal injury estimation in 
GBD 2017 was that long- term follow- up studies used for injury 
severity hierarchies and probabilities of long- term disability are 
only available in select countries. Future GBD updates should 
focus on adding more data to inform this analytical process.
ConCLusIon
This study further substantiates the key messages highlighted in 
the Global Status Report on Road Safety 2018 by the WHO. 
In particular, despite improvements in mortality, road injuries 
remain critically important cause of morbidity and mortality 
globally, and more research is needed to better measure and 
understand how road injuries can be prevented, particularly in 
developing economies. Investing in preventative measures as 
well as ensuring that victims of road injuries have access to first 
response trauma and medical care could help drive improve-
ments in road injury burden in the future.
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